Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / CL B
-
Total 13F shares
-
109,107
-
Share change
-
-1,194
-
Total reported value
-
$82,364,000
-
Price per share
-
$755.18
-
Number of holders
-
12
-
Value change
-
-$898,882
-
Number of buys
-
2
-
Number of sells
-
2
Institutional Holders of BIO RAD LABS INC - CL B (BIOB) as of Q4 2021
As of 31 Dec 2021,
BIO RAD LABS INC - CL B (BIOB) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
109,107 shares.
The largest 10 holders included
Tikvah Management LLC, CSS LLC/IL, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GAMCO INVESTORS, INC. ET AL, UBS Group AG, OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC, Gemmer Asset Management LLC, and WELLS FARGO & COMPANY/MN.
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.